arginine has been researched along with isosorbide-5-mononitrate in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Capasso, F; Gaginella, TS; Izzo, AA; Mascolo, N | 1 |
Albino-Teixeira, A; Soares-da-Silva, P | 1 |
Autore, G; Barbato, F; Capasso, F; Izzo, AA; Mascolo, N | 1 |
Barin, ES; Gilfillan, KL; Kaesemeyer, WH; Stokes, GS | 1 |
Chiossi, G; de Pace, V; Facchinetti, F | 1 |
Chen, C; Dong, DL; Gao, LL; Hu, JT; Liang, J; Tu, YJ; Wang, ZG; Wu, JC; Yang, BF | 1 |
Li, H; Wang, S | 1 |
Cheng, FY; Lü, HX; Zhang, ZH; Zhou, JP | 1 |
1 review(s) available for arginine and isosorbide-5-mononitrate
Article | Year |
---|---|
Clinical use of nitric oxide donors and L-arginine in obstetrics.
Topics: Amniotic Fluid; Arginine; Biomarkers; Cervical Ripening; Female; Fetal Growth Retardation; Humans; Hypertension, Pregnancy-Induced; Isosorbide Dinitrate; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Obstetric Labor, Premature; Pregnancy; Uterine Contraction; Version, Fetal | 2007 |
2 trial(s) available for arginine and isosorbide-5-mononitrate
Article | Year |
---|---|
Interactions of L-arginine, isosorbide mononitrate, and angiotensin II inhibitors on arterial pulse wave.
Topics: Aged; Aged, 80 and over; Angiotensin II; Arginine; Arteries; Blood Pressure; Circadian Rhythm; Cross-Over Studies; Diastole; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide Donors; Posture; Pulse; Systole; Time Factors; Treatment Outcome; Vasoconstrictor Agents | 2003 |
Organic nitrates favor regression of left ventricular hypertrophy in hypertensive patients on chronic peritoneal dialysis.
Topics: Adult; Aged; Antihypertensive Agents; Arginine; Blood Pressure; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Prospective Studies; Time Factors; Treatment Outcome; Vasodilator Agents | 2013 |
6 other study(ies) available for arginine and isosorbide-5-mononitrate
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Dissociation of castor oil-induced diarrhoea and intestinal mucosal injury in rat: effect of NG-nitro-L-arginine methyl ester.
Topics: Acid Phosphatase; Animals; Arginine; Castor Oil; Diarrhea; Dose-Response Relationship, Drug; Gastrointestinal Hemorrhage; Intestinal Mucosa; Isosorbide Dinitrate; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Vasodilator Agents | 1994 |
Isosorbide 5-mononitrate reverses high blood pressure in NG-nitro-L-arginine methyl ester treated rats.
Topics: Animals; Arginine; Blood Pressure; Brain; Dopamine; Drinking; Drug Interactions; Epinephrine; Heart Rate; Hypertension; Isosorbide Dinitrate; Male; Methoxyhydroxyphenylglycol; NG-Nitroarginine Methyl Ester; Norepinephrine; Rats; Rats, Wistar; Sympathetic Nervous System; Tissue Distribution; Vasodilator Agents | 1994 |
Nitric oxide and castor oil-induced diarrhea.
Topics: Animals; Arginine; Body Fluids; Castor Oil; Diarrhea; Electrolytes; Gastrointestinal Motility; Intestine, Small; Isosorbide Dinitrate; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar | 1994 |
Effects of isosorbide mononitrate on the restoration of injured artery in mice in vivo.
Topics: Animals; Arginine; Carotid Artery Injuries; Electric Stimulation; Endothelial Cells; Isosorbide Dinitrate; Mice | 2010 |
[The effects and its mechanism of N-arginine chitosan as transdermal enhancer].
Topics: Administration, Cutaneous; Animals; Arginine; Aspirin; Cell Line; Cell Survival; Cell-Penetrating Peptides; Chitosan; Drug Carriers; Humans; Isosorbide Dinitrate; Keratinocytes; Male; Mice; Prazosin; Skin Absorption | 2013 |